07 April 2022
The Pharmaceutical Journal cites Chief Executive
Chief executive of ASH, Deborah Arnott, is quotes in the Pharmaceutical Journal, responding to their story ‘No new licence applications for e-cigarettes since UK medicines regulator changed its guidance’: “Making an application for a medicinal license requires the pulling together of a very detailed dossier which can take significantly longer than six months.” “That no applications have yet been made is no reflection on consumer e-cigarettes currently on the market, which already meet safety standards which are set and overseen by the MHRA [Medicines and Healthcare products Regulatory Agency].”